Yuefeng Yang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- CAR-T cell therapy research
Papers in
-
- Circular RNAs in diseases 4
- RNA Interference and Gene Delivery 3
- Fibroblast Growth Factor Research 3
- Genetics 13
- Virus-based gene therapy research 12
- Co-authors
- Fengjun Xiao (15 shared papers)Lisheng Wang (5 shared papers)Hua Wang (9 shared papers)Prem Seth (10 shared papers)Yuanxiang Jin (3 shared papers)Cheng Zhou (3 shared papers)Zhengwei Fu (3 shared papers)Linggang Wang (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (5 papers)Human Gene Therapy (5 papers)Molecular Neurobiology (2 papers)Cancer Gene Therapy (2 papers)Molecular Therapy (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Yuefeng Yang
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 91
- Cancer Research 341
- Oncology 267
- Health, Toxicology and Mutagenesis 114
- Genetics 224
- Biotechnology 71
Countries citing papers authored by Yuefeng Yang
This map shows the geographic impact of Yuefeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuefeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuefeng Yang more than expected).
Fields of papers citing papers by Yuefeng Yang
This network shows the impact of papers produced by Yuefeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuefeng Yang. The network helps show where Yuefeng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuefeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 147 | |
| 2 | 2011 | 92 | |
| 3 | 2011 | 76 | |
| 4 | 2011 | 75 | |
| 5 | 2020 | 68 | |
| 6 | 2015 | 63 | |
| 7 | 2015 | 48 | |
| 8 | MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27. | 2014 | 47 |
| 9 | 2019 | 45 | |
| 10 | 2017 | 42 | |
| 11 | Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23/IL-17 axis. | 2018 | 40 |
| 12 | 2016 | 33 | |
| 13 | 2014 | 30 | |
| 14 | 2016 | 30 | |
| 15 | 2010 | 29 | |
| 16 | 2014 | 27 | |
| 17 | 2018 | 23 | |
| 18 | 2020 | 21 | |
| 19 | 2011 | 21 | |
| 20 | 2017 | 20 |
About Yuefeng Yang
Yuefeng Yang is a scholar working on Molecular Biology, Genetics, Cancer Research, Biotechnology and Oncology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (12 papers), Cancer Research and Treatments (9 papers), MicroRNA in disease regulation (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Circular RNAs in diseases (4 papers), RNA Interference and Gene Delivery (3 papers), CAR-T cell therapy research (3 papers) and Fibroblast Growth Factor Research (3 papers). The work is most often cited by research in Cancer Research (341 citations), Oncology (267 citations), Health, Toxicology and Mutagenesis (114 citations), Genetics (224 citations) and Biotechnology (71 citations). Yuefeng Yang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Fengjun Xiao, Lisheng Wang, Hua Wang, Prem Seth, Yuanxiang Jin, Cheng Zhou, Zhengwei Fu, Linggang Wang, Yuxiang Li and Lin Zhang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Human Gene Therapy, Molecular Neurobiology, Cancer Gene Therapy and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.